10th Jan 2011 16:24
SkyePharma announces appointment of Corporate Broker
LONDON, UK, 10 January 2011 - SkyePharma PLC (LSE: SKP) today announces the appointment of Singer Capital Markets Limited as financial adviser and Corporate Broker to the Company with immediate effect.
In addition, the Company's new address, also with immediate effect, is 46-48 Grosvenor Gardens, London, SW1W 0EB; telephone +44 207 881 0524.
For further information please contact:
SkyePharma PLC |
|
Axel Müller, Chief Executive Officer | +44 207 881 0524 |
Peter Grant, Chief Financial Officer |
|
|
|
Singer Capital Markets Limited |
|
Shaun Dobson / Claes Spång | +44 203 205 7500 |
|
|
Financial Dynamics |
|
Jonathan Birt /Sue Quigley | +44 207 831 3113 |
|
|
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Group has twelve approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.
Related Shares:
SKP.L